(MABT) and (Accelero) are pleased to announce a research collaboration to identify novel USP30 inhibitors
DOYLESTOWN, Pa., Sept. 4, 2024 /PRNewswire/ — Mid-Atlantic BioTherapeutics (MABT) and Accelero Biostructures (Accelero) are pleased to announce a research collaboration to identify novel USP30 inhibitors targeting neurological disorders and other important …